4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > Other_reagents > Adipogen/Vinpocetine/AG-CN2-0454-M020/20 mg
商品详细Adipogen/Vinpocetine/AG-CN2-0454-M020/20 mg
Adipogen/Vinpocetine/AG-CN2-0454-M020/20 mg
Adipogen/Vinpocetine/AG-CN2-0454-M020/20 mg
商品编号: AG-CN2-0454-M020
品牌: Adipogen Inc
市场价: ¥1000.00
美元价: 600.00
产地: 美国(厂家直采)
公司:
产品分类: 其他试剂
公司分类: Other_reagents
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
MoreInformation
ProductDetails
SynonymsVPC;(3α,16α)-Eburnamenine-14-carboxylicacidethylester;Ethylapovincaminate;RGH-4405;TCV3B;AY27255
ProductTypeChemical
Properties
FormulaC22H26N2O2
MW350.5
MerckIndex14:9991
CAS42971-09-5
RTECSJW4792000
Source/HostChemicalsSemi-syntheticfromVoacangaafricana.
PurityChemicals≥98%(HPLC)
AppearanceWhitetoslightlyyellowcrystallinepowder.
SolubilitySolubleinDMSO,dichloromethane,acetoneor100%ethanol.Insolubleinwater.
IdentityDeterminedby1H-NMR.
InChiKeyDDNCQMVWWZOMLN-IRLDBZIGSA-N
ShippingandHandling
ShippingAMBIENT
ShortTermStorage+20°C
LongTermStorage+20°C
HandlingAdviceProtectfromlightandmoisture.
Use/StABIlityStableforatleast2yearsafterreceiptwhenstoredat+20°C.
Documents
MSDSDownloadPDF
ProductSpecificationSheet
DatasheetDownloadPDF
  • SelectiveCa2+-calmodulindependentcGMP-phosphodiesterase(PDE1)inhibitor.Showsvasorelaxantactivity.
  • Neuroprotectiveagent.
  • Selectivelyinhibitsvoltage-sensitiveNa2+channels
  • Potentanti-inflammatoryagent.
  • InhibitorofNF-κB-dependentinflammatoryresponsesbydirectlytargetingIKK.
  • ShowntoinhibittheNLRP3inflammasome.
  • Antioxidant.FreerADIcalscavenger.
  • Anticancercompound.
  • Anticonvulsant.
  • Attenuatesosteoblasticdifferentiationofvascularsmoothmusclecells.
ProductReferences
  1. Effectsofselectiveinhibitorsoncyclicnucleotidephosphodiesterasesofrabbitaorta:H.S.Ahn,etal.;Biochem.Pharmacol.38,3331(1989)
  2. RoleofselectivecyclicGMPphosphodiesteraseinhibitioninthemyorelaxantactionsofM&B22,948,MY-5445,vinpocetineand1-methyl-3-isobutyl-8-(methylamino)xanthine:J.E.Souness,etal.;Br.J.Pharmacol.98,725(1989)
  3. Vinpocetineselectivelyinhibitsneurotransmitterreleasetriggeredbysodiumchannelactivation:M.Sitges&V.Nekrassov;NeuRochem.Res.24,1585(1999)
  4. Invitroantioxidantpropertiesofpentoxifylline,piracetam,andvinpocetine:B.Horvath,etal.;Clin.Neuropharmacol.25,37(2002)
  5. EffectsofVinpocetineonmitochondrialfunctionandneuroprotectioninprimarycorticalneurons:K.Tarnok,etal.;Neurochem.Int.53,289(2008)
  6. Ameliorationofintracerebroventricularstreptozotocininducedcognitivedysfunctionandoxidativestressbyvinpocetine-aPDE1inhibitor:R.Deshmukh,etal.;Eur.J.Pharmacol.620,49(2009)
  7. VinpocetineinhibitsNF-kappaB-dependentinflammationviaanIKK-dependentbutPDE-independentmechanism:K.I.Jeon,etal.;PNAS107,9795(2010)
  8. Vinpocetineasapotentantiinflammatoryagent:A.E.Medina,etal.;PNAS107,9921(2010)
  9. Vinpocetineinhibitsbreastcancercellsgrowthinvitroandinvivo:E.W.Huang,etal.;Apoptosis17,1120(2012)
  10. Vinpocetineattenuateslipidaccumulationandatherosclerosisformation:Y.Cai,etal.;BBRC434,439(2013)
  11. Theanti-seizuredrugsvinpocetineandcarbamazepine,butnotvalproicacid,reduceinflammatoryIL-1betaandTNF-alphaexpressioninrathippocampus:C.D.Gomez,etal.;J.Neurochem.130,770(2014)
  12. Anti-inflammatoryeffectsofvinpocetineinatherosclerosisandischemicstroke:areviewoftheliterature:L.Zhang&L.Yang;Molecules20,335(2014)
  13. Vinpocetineinhibitsamyloid-betainducedactivationofNF-κB,NLRP3inflammasomeandcytokineproductioninretinalpigmentepithelialcells:R.T.Liu,etal.;Exp.EyeRes.127,49(2014)
  14. Vinpocetinemodulatesmetabolicactivityandfunctionduringretinalischemia:L.Nivison-Smith,etal.;Am.J.Physiol.CellPhysiol.308,737(2015)
  15. Vinpocetinereduceslipopolysaccharide-inducedinflammatorypainandneutrophilrecruitmentinmicebytargetingoxidativestress,cytokinesandNF-κB:K.W.Ruiz-Miyazawa,etal.;Chem.Biol.Interact.237,9(2015)
  16. Vinpocetineattenuatesosteoblasticdifferentiationofvascularsmoothmusclecells:Y.Y.Ma,etal.;PLoSOne11,e0162295(2016)
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。